G
Gabriela Schmajuk
Researcher at University of California, San Francisco
Publications - 138
Citations - 6269
Gabriela Schmajuk is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 27, co-authored 109 publications receiving 3594 citations. Previous affiliations of Gabriela Schmajuk include University of California & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Quality of care for patients with SLE: data from the American College of Rheumatology's RISE registry
Gabriela Schmajuk,Gabriela Schmajuk,Jing Li,Michael J. Evans,Christine Anastasiou,Julia Kay,Jinoos Yazdany +6 more
TL;DR: A group of quality measures relevant to the care of patients with SLE are applied, and the Rheumatology Informatics System for Effectiveness registry is used to assess nationwide variations in care.
Journal ArticleDOI
Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry
Marie Humbert-Droz,Zara Izadi,Gabriela Schmajuk,Milena A. Gianfrancesco,Matthew C. Baker,Jinoos Yazdany,Suzanne Tamang +6 more
TL;DR: An NLP pipeline to extract RA outcome measures from a national registry of notes from multiple EHR systems and found it to have good internal and external validity.
Journal ArticleDOI
SAT-418 Finding the Needles in the Haystack: Harnessing the Electronic Health Record to Find Thyroid Immune Related Adverse Events
Zoe Quandt,Laura Trupin,Michael J. Evans,Gabriela Schmajuk,Mark S. Anderson,Jeff A Bluestone,Yazdany Jinoos +6 more
TL;DR: Thyroid irAEs are much more common in real world practice than in clinical trials and there is emerging evidence that certain cancer types incur a higher risk of thyroid IRAEs even after adjustment for CPI exposure.
Journal ArticleDOI
Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate
Gabriela Schmajuk,Gabriela Schmajuk,Chris Tonner,Yinghui Miao,Jinoos Yazdany,Jacqueline Gannon,W. John Boscardin,David I. Daikh,David I. Daikh,Michael A. Steinman,Michael A. Steinman +10 more
TL;DR: In a nationwide VHA cohort of new users of oral MTX, many patients did not receive folic acid or discontinued it over time, highlighting the need to improve patient safety for users of methotrexate by standardizing workflows for folic Acid supplementation.
The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology.
Meera Subash,Lucy H Liu,Kimberly DeQuattro,Sonam Choden,Lindsay Jacobsohn,Patricia P. Katz,Puneet Bajaj,Jennifer L. Barton,Christie M. Bartels,Bonnie L. Bermas,Maria I. Danila,Christina Downey,Sancia Ferguson,Kimberly Reiter,Elizabeth Wahl,Elena Weinstein,JoAnn Zell,Gabriela Schmajuk,Jinoos Yazdany +18 more
TL;DR: The RISE LC (Rheumatology Informatics System for Effectiveness Learning Collaborative) was established to develop and share best practices in patient-reported outcomes (PROs) collection and use across adult rheumatologists in the United States as discussed by the authors.